CUTTING EDGE SCIENCE

ABOUT

Hylomorph is a Medtech Startup company, spin-off of the Swiss Federal Institute of Technology.

We specialize in cutting-edge combination of micro-engineering and biotechnology into innovative biomaterials for healthcare products.

Hylomorph's core technology optimizes the interface between implantable medical devices and the biological tissues.

Our headquarter is based at Technopark Zurich, in the heart of Switzerland.

Curious to know more about what we do? Click below and listen to Hylomorph CEO, Dr. Simone Bottan.

TEAM

Credits: Lichtsteiner Foundation

Simone Bottan
  • LinkedIn Social Icon
Simone Bottan

CHIEF EXECUTIVE OFFICER

Francesco Robotti
  • LinkedIn Social Icon
Francesco Robotti

CHIEF OPERATING OFFICER

Aldo Ferrari
  • LinkedIn Social Icon
Aldo Ferrari

CHIEF SCIENTIFIC OFFICER

Sonia Schmocker
  • LinkedIn Social Icon
Sonia Schmocker

CHIEF REGULATORY & QUALITY OFFICER

Sebastian Cavalli
  • LinkedIn Social Icon
Sebastian Cavalli

QUALITY SPECIALIST

Georgios Stefopoulos
  • LinkedIn Social Icon
Georgios Stefopoulos

PROJECT MANAGER

Lucia Gasparovic
  • LinkedIn Social Icon
Lucia Gasparovic

REGULATORY & QUALITY

ASSOCIATE

ID photo _Eunice Nazario_1.jpg
  • LinkedIn Social Icon
Eunice Nazario

PRODUCT ENGINEER

BOARD OF DIRECTORS

Gian-Luigi Berini
  • LinkedIn Social Icon
Gian-Luigi Berini

BOARD CHAIRMAN

Simone Bottan
  • LinkedIn Social Icon
Simone Bottan

CHIEF EXECUTIVE OFFICER

Peter Gabriel
  • LinkedIn Social Icon
Peter Gabriel

BOARD MEMBER

Aldo Ferrari
  • LinkedIn Social Icon
Aldo Ferrari

CHIEF SCIENTIFIC OFFICER

AWARDS AND SUPPORT

Spin off ETH
vk_logo
LS_Logo_Schwarz
eurostars logo
Logo_Wyss_Zürich
Innosuisse logo
Venture Leaders Logo
flag_yellow_high

Co-funded by the Horizon 2020 programme of the European Union